These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23997284)

  • 21. Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project.
    Ulph F; Wright S; Dharni N; Payne K; Bennett R; Roberts S; Walshe K; Lavender T
    Health Technol Assess; 2017 Oct; 21(55):1-240. PubMed ID: 28967862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples.
    Haga SB
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):587-92. PubMed ID: 20858049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes of parents of children with serious health conditions regarding residual bloodspot use.
    Nagaraj CB; Rothwell E; Hart K; Latimer S; Schiffman JD; Botkin JR
    Public Health Genomics; 2014; 17(3):141-8. PubMed ID: 24713606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contamination of dried blood spots - an underestimated risk in newborn screening.
    Winter T; Lange A; Hannemann A; Nauck M; Müller C
    Clin Chem Lab Med; 2018 Jan; 56(2):278-284. PubMed ID: 28763295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the newborn screening education needs of families living in medically underserved areas.
    Evans A; Lynch M; Johnson M; Bonhomme N
    J Genet Couns; 2020 Aug; 29(4):658-667. PubMed ID: 32227550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study.
    Jansen ME; van den Bosch LJM; Hendriks MJ; Scheffer MMJ; Heijnen ML; Douglas CMW; van El CG
    BMC Pediatr; 2019 Jul; 19(1):230. PubMed ID: 31288776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Cool! and creepy': engaging with college student stakeholders in Michigan's biobank.
    Platt T; Platt J; Thiel DB; Fisher N; Kardia SL
    J Community Genet; 2014 Oct; 5(4):349-62. PubMed ID: 24916145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.
    Rothwell EW; Anderson RA; Burbank MJ; Goldenberg AJ; Lewis MH; Stark LA; Wong B; Botkin JR
    Am J Public Health; 2011 Nov; 101(11):2111-6. PubMed ID: 21330580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of parental consent process for newborn screening in Taiwan.
    Huang MC; Lee CK; Lin SJ; Lu IC
    Acta Paediatr Taiwan; 2005; 46(6):361-9. PubMed ID: 16640039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mandatory versus voluntary consent for newborn screening?
    Ross LF
    Kennedy Inst Ethics J; 2010 Dec; 20(4):299-328. PubMed ID: 21338027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options.
    Hayeems RZ; Miller FA; Barg CJ; Bombard Y; Cressman C; Painter-Main M; Wilson B; Little J; Allanson J; Avard D; Giguere Y; Chakraborty P; Carroll JC
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking.
    Douglas CM; van El CG; Faulkner A; Cornel MC
    Croat Med J; 2012 Aug; 53(4):390-7. PubMed ID: 22911534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
    Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
    Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.
    Joseph G; Chen F; Harris-Wai J; Puck JM; Young C; Koenig BA
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S36-46. PubMed ID: 26729702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digital peer-to-peer information seeking and sharing: Opportunities for education and collaboration in newborn screening.
    Miller BC; Goldenberg AJ; Bonhomme NF
    Am J Med Genet C Semin Med Genet; 2021 Mar; 187(1):64-69. PubMed ID: 33502079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obtaining consent from both parents for pediatric research: what does "reasonably available" mean?
    Nelson DK; Skinner D; Guarda S; Choudhury S; Sideris J; Barnum L; Ten Haagen K; Heyward Q; Bailey DB
    Pediatrics; 2013 Jan; 131(1):e223-9. PubMed ID: 23266920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foundation of the Newborn Screening Translational Research Network and its tools for research.
    Lloyd-Puryear M; Brower A; Berry SA; Brosco JP; Bowdish B; Watson MS
    Genet Med; 2019 Jun; 21(6):1271-1279. PubMed ID: 30393376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.